NB-UVB phototherapy in the treatment of anti-PD-1 inhibitor induced psoriasis: A case report

[1]  B. Strober,et al.  Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with phototherapy. , 2019, Journal of the American Academy of Dermatology.

[2]  C. Ko,et al.  Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single‐institution retrospective analysis with stratification of reactions by toxicity and implications for management , 2019, Journal of the American Academy of Dermatology.

[3]  N. Isakov.  Cancer immunotherapy by targeting immune checkpoint receptors , 2018, World Journal of Immunology.

[4]  A. Chang,et al.  Characterization of dermatitis after PD‐1/PD‐L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case‐control study , 2018, Journal of the American Academy of Dermatology.

[5]  E. Hulstaert,et al.  Psoriasis Vulgaris Exacerbation during Treatment with a PD-1 Checkpoint Inhibitor: Case Report and Literature Review , 2018, Case Reports in Dermatology.

[6]  Rajan P Kulkarni,et al.  Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management , 2018, Therapeutic advances in medical oncology.

[7]  G. Jeudy,et al.  Anti‐PD1‐induced psoriasis: a study of 21 patients , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  R. Botella-Estrada,et al.  Análisis retrospectivo del papel de la fototerapia en la enfermedad injerto contra huésped crónica cutánea. Revisión de la literatura , 2015 .

[9]  J. Wolchok,et al.  Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  C. Punt,et al.  PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer , 2012, Journal of immunotherapy.

[11]  R. Storb,et al.  The role of B cells in the pathogenesis of graft-versus-host disease. , 2009, Blood.

[12]  F. Nestle,et al.  The IL-23/Th17 axis in the immunopathogenesis of psoriasis. , 2009, The Journal of investigative dermatology.

[13]  S. George.  Adverse effects with PUVA and UVB phototherapy , 2001, The Journal of dermatological treatment.

[14]  E. Prens,et al.  Phototherapy of Psoriasis, a Chronic Inflammatory Skin Disease. , 2017, Advances in experimental medicine and biology.